Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05126758 HOPE-3 — A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulat… |
Deramiocel (CAP-1002) | Myopathies | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Capricor Inc. | United States · Akron Children's Hospital, Akron, Uni… | 2022-06-22 → 2027-03 | Ouvrir |
| NCT00341679 Studies of the Natural History and Pathogenesis of Autoimmune/Connectiv… |
Studies of the Natural History an… | Myopathies | À vérifier | COMPLETED | En attente / non publié | National Institute of Environment… | United States · National Institute of Environmental H… | 2005-07-13 | Ouvrir |
| NCT02633163 Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus… |
Low Dose Mesenchymal Stem Cells (… | Lupus | Phase 2 | COMPLETED | En attente / non publié | Medical University of South Carol… | United States · Cedars-Sinai Medical Center, Los Ange… | 2018-11-18 → 2026-02-03 | Ouvrir |
| NCT06711887 Phase III Extension Study of Efficacy and Safety of Ianalumab With or W… |
Ianalumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Brazil, China, Colombia, Czechia, Fran… | 2025-05-19 → 2035-08-01 | Ouvrir |
| NCT07783711 Predictors of ICU Admission and In-Hospital Mortality in Hospitalized P… |
Predictors of ICU Admission and I… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Khaled Samir Malak Nashed | Non communiqué | 2026-09 → 2028-10-01 | Ouvrir |
| NCT07767188 A Trial to Explore the Efficacy and Safety of O-triple as Initial Thera… |
obinutuzumab (RO5072759) | Lupus | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Zhao Minghui | China · Fujian Medical University Union Hospital, Fuz… | 2026-09-10 → 2029-05-08 | Ouvrir |
| NCT06121297 RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Effi… |
CABA-201 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Cabaletta Bio | United States, Canada, Spain · Boston Children's Hosp… | 2024-02-16 → 2029-12 | Ouvrir |
| NCT05001737 EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emap… |
Emapalumab | Lupus | Phase 3 | COMPLETED | En attente / non publié | Swedish Orphan Biovitrum | United States, Belgium, Canada, China, Czechia, Franc… | 2021-12-15 → 2025-06-04 | Ouvrir |
| NCT05818254 HOP-STEPsIRB — The HOP-STEP Intervention: Improving Maternal Health in … |
HOP-STEPsIRB — The HOP-STEP Inter… | Lupus | Non applicable | COMPLETED | En attente / non publié | Duke University | United States · University of Chicago Medical Center,… | 2024-10-07 → 2026-07-31 | Ouvrir |
| NCT07323173 A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and… |
LBL-047 for Injection | Lupus | Phase 1 | RECRUITING | En attente / non publié | Nanjing Leads Biolabs Co.,Ltd | China · Beijing GoBroad Hospital, Beijing, China | Mi… | 2025-12-16 → 2027-12-16 | Ouvrir |
| NCT07053800 LUMINA — Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SL… |
Obecabtagene autoleucel | Lupus | Phase 2 | RECRUITING | En attente / non publié | Autolus Limited | United States, Brazil, Greece, United Kingdom, Vietna… | 2026-01-16 → 2029-10 | Ouvrir |
| NCT07438496 GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe… |
Nipocalimab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Argentina, Australia, Brazil, Bulgaria… | 2026-03-05 → 2031-11-07 | Ouvrir |
| NCT06980805 A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 i… |
IMVT-1402 | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Immunovant Sciences GmbH | United States, Argentina, Bulgaria, Canada, Chile, Ge… | 2025-02-19 → 2027-04 | Ouvrir |
| NCT07424261 VIOLET — NIS to Examine Disease Activity in SLE Patients Treated With S… |
VIOLET — NIS to Examine Disease A… | Lupus | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Germany · Research Site, Altenburg, Germany | Researc… | 2026-03-19 → 2029-08-31 | Ouvrir |
| NCT06513429 IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) |
IM19 CAR-T cells | Lupus | Non applicable | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking Universitiy Third Hospital, Beijing, C… | 2024-07-30 → 2027-12-31 | Ouvrir |
| NCT06342960 KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR… |
KYV-101 anti-CD19 CAR-T cell ther… | Lupus | Phase 1/2 | TERMINATED | En attente / non publié | Kyverna Therapeutics | Germany · Charite- Universitätsklinikum Berlin, Berli… | 2022-12-01 → 2025-12-22 | Ouvrir |
| NCT05938725 KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR… |
KYV-101 anti-CD19 CAR-T cell ther… | Lupus | Phase 1/2 | TERMINATED | En attente / non publié | Kyverna Therapeutics | United States · Northwell Health, Great Neck, United … | 2023-04-28 → 2026-05-29 | Ouvrir |
| NCT04009863 HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic… |
Echopulse | Cancer | Non applicable | COMPLETED | En attente / non publié | The University of Hong Kong | Hong Kong · Queen Mary Hospital, Hong Kong, Hong Kong | 2020-04-01 → 2022-04-30 | Ouvrir |
| NCT03996005 MRI-TULSAP — MRI- Guided Transurethral Ultrasound Ablation of Localized… |
Magnetic Resonance Imaging-Guided… | Cancer | Non applicable | COMPLETED | En attente / non publié | University Hospital, Strasbourg, … | France · Hopitaux Universitaires de Strasbourg, Stras… | 2019-09-24 → 2023-07-25 | Ouvrir |
| NCT04791228 A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid … |
Magnetic Resonance-Guided High In… | Cancer | Phase 2 | WITHDRAWN | En attente / non publié | Children's National Research Inst… | United States · Children's National Hospital, Washing… | 2022-11-10 → 2024-12-23 | Ouvrir |
| NCT05363657 i-RECORd — International REgistry of COnservative or Radical Treatment … |
Partial Nephrectomy (PN) | Cancer | À vérifier | RECRUITING | En attente / non publié | Azienda Ospedaliero-Universitaria… | United States, Austria, Belgium, Brazil, Greece, Ital… | 2022-01-10 → 2028-12-31 | Ouvrir |
| NCT07376837 PTC-RFA — Radiofrequency Ablation for Curative Treatment of Small Low-R… |
Radiofrequency Ablation of Papill… | Cancer | Non applicable | RECRUITING | En attente / non publié | University Health Network, Toronto | Canada · University Health Network - Princess Margare… | 2026-02-05 → 2027-07-01 | Ouvrir |
| NCT03248375 Impact of Y90 Radiation Segmentectomy on HCC |
Radiation Segmentectomy | Cancer | Non applicable | COMPLETED | En attente / non publié | Icahn School of Medicine at Mount… | United States · Icahn School of Medicine at Mount Sin… | 2016-08-03 → 2021-03-31 | Ouvrir |
| NCT07628751 SOCRATES HCC — A Study of Standard Of Care Versus Radio Ablation in Ear… |
Stereotactic Ablative Body Radiot… | Cancer | Non applicable | RECRUITING | En attente / non publié | University Health Network, Toronto | Australia, Canada · Trans Tasman Radiation Oncology G… | 2026-05-11 → 2032-04-01 | Ouvrir |
| NCT04699773 LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 2… |
LITT | Cancer | Non applicable | RECRUITING | En attente / non publié | University of Maryland, Baltimore | United States · Baltimore Washington Medical Center, … | 2021-02-20 → 2027-12 | Ouvrir |